Improving fecal occult blood testing compliance using a mailed educational reminder

Jeffrey K Lee, Veronica Reis, Shanglei Liu, Lorraine Conn, Erik J Groessl, Theodore G Ganiats, Samuel B Ho, Jeffrey K Lee, Veronica Reis, Shanglei Liu, Lorraine Conn, Erik J Groessl, Theodore G Ganiats, Samuel B Ho

Abstract

Background: Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths in the United States. Randomized controlled trials have shown that annual screening fecal occult blood testing (FOBT) reduces CRC mortality and incidence. However, patient compliance with FOBT is low.

Objective: To determine whether a mailed educational reminder increases FOBT card return rates and to examine predictors of FOBT compliance.

Design: Blinded, randomized, controlled trial at the Veteran Affairs Medical Center, San Diego, California.

Patients: Seven hundred and seventy-five consecutive patients > or =50 years of age referred by their primary care physicians for FOBT.

Intervention: Patients were randomly assigned to the usual care group or the intervention group. Ten days after picking up the FOBT cards, a 1-page reminder with information related to CRC screening was mailed to the intervention group only.

Measurements: The primary outcome was proportion of returned FOBT cards after 6 months. Patient demographic, clinical characteristics and prior FOBT completed were collected for multivariate regression analysis.

Results: At 6 months after card distribution, 64.6% of patients in the intervention group returned cards compared with 48.4% in the control group (P < 0.001). Patients who received a mailed reminder (OR 2.02; 95% CI: 1.48-2.74) or have a prior history of returning the FOBT cards (OR 1.87; 95% CI: 1.29-2.70) were more likely to return the FOBT cards. Patients with current or recent illicit drug use were less likely to return the FOBT cards (OR 0.26; 95% CI: 0.13-0.50).

Conclusion: A simple mailed educational reminder significantly increases compliance with FOBT for CRC screening.

Trial registration: ClinicalTrials.gov NCT00534053.

Figures

Figure 1
Figure 1
Flow Diagram through the study. CRC: Colorectal Cancer.
Figure 2
Figure 2
Cumulative adherence over time by study. FOBT: Fecal Occult Blood Test.

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.3322/CA.2007.0010', 'is_inner': False, 'url': 'https://doi.org/10.3322/ca.2007.0010'}, {'type': 'PubMed', 'value': '18287387', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/18287387/'}]}
    2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '18340331', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/18340331/'}]}
    2. Centers for Disease Control and Prevention (CDC). Use of colorectal cancer tests – United States., 2002, 2004, and 2006. Morb Mortal Wkly Rep. 2008;57(10):253–58.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0140-6736(96)03386-7', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0140-6736(96)03386-7'}, {'type': 'PubMed', 'value': '8942775', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/8942775/'}]}
    2. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–7.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0140-6736(96)03430-7', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0140-6736(96)03430-7'}, {'type': 'PubMed', 'value': '8942774', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/8942774/'}]}
    2. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–71.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '18838716', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/18838716/'}]}
    2. Screening for colorectal cancer: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:627–37.
    1. National Comprehensive Cancer Network (NCCN). Colorectal cancer screening. Clinical Practice Guidelines in Oncology — v.1.2009. Jenkintown, PA: NCCN; 2009. Available at: Accessed July, 2009.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1053/gast.2003.50044', 'is_inner': False, 'url': 'https://doi.org/10.1053/gast.2003.50044'}, {'type': 'PubMed', 'value': '12557158', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/12557158/'}]}
    2. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003;124:544–60.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12118972', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/12118972/'}]}
    2. Pignone M, Rich M, Teutsch SM, et al. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:132–41.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1093/jnci/89.19.1406', 'is_inner': False, 'url': 'https://doi.org/10.1093/jnci/89.19.1406'}, {'type': 'PubMed', 'value': '9326910', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/9326910/'}]}
    2. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89:1406–22.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/1097-0142(19800615)45:12<2955::AID-CNCR2820451211>3.0.CO;2-T', 'is_inner': False, 'url': 'https://doi.org/10.1002/1097-0142(19800615)45:12<2955::aid-cncr2820451211>3.0.co;2-t'}, {'type': 'PubMed', 'value': '7388738', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/7388738/'}]}
    2. Winchester DP, Shull JH, Scanlon EF, et al. A mass screening program for colorectal cancer using chemical testing for occult blood in the stool. Cancer. 1980;45:2955–8.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1111/j.1525-1497.2005.40023.x', 'is_inner': False, 'url': 'https://doi.org/10.1111/j.1525-1497.2005.40023.x'}, {'type': 'PMC', 'value': 'PMC1490069', 'is_inner': False, 'url': 'http://www.ncbi.nlm.nih.gov/pmc/articles/pmc1490069/'}, {'type': 'PubMed', 'value': '15836533', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15836533/'}]}
    2. Stokamer CL, Tenner CT, Chaudhuri J, Vazquez E, Bini EJ. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing. J Gen Intern Med. 2005;20:278–82.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8532551', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/8532551/'}]}
    2. Mahon SM. The impact of mailing fecal occult blood test kits on return rate in a community cancer screening center. Oncol Nurs Forum. 1995;22:1259–63.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0749-3797(97)00003-2', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0749-3797(97)00003-2'}, {'type': 'PubMed', 'value': '9476837', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/9476837/'}]}
    2. Wagner TH. The effectiveness of mailed patient reminders on mammography screening: a meta-analysis. Am J Prev Med. 1998;14:64–70.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1046/j.1525-1497.2001.016008567.x', 'is_inner': False, 'url': 'https://doi.org/10.1046/j.1525-1497.2001.016008567.x'}, {'type': 'PMC', 'value': 'PMC1495254', 'is_inner': False, 'url': 'http://www.ncbi.nlm.nih.gov/pmc/articles/pmc1495254/'}, {'type': 'PubMed', 'value': '11556935', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/11556935/'}]}
    2. Tseng DS, Cox E, Plane MB, Hla KM. Efficacy of patient letter reminders on cervical cancer screening: a meta-analysis. J Gen Intern Med. 2001;16:563–8.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8770470', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/8770470/'}]}
    2. Richardson JL, Mondrus GT, Danley K, Deapen D, Mack T. Impact of a mailed intervention on annual mammography and physician breast examinations among women at high risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 1996;5:71–6.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '17179058', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/17179058/'}]}
    2. Denberg TD, Coombes JM, Byers TE, et al. Effect of a mailed brochure on appointment-keeping for screening colonoscopy: a randomized trial. Ann Intern Med. 2006;145:895–900.
    1. The Flesch Reading Ease Readability Formula. Available at Accessed July, 2009.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJM199305133281901', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejm199305133281901'}, {'type': 'PubMed', 'value': '8474513', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/8474513/'}]}
    2. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–71.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1007/BF02562123', 'is_inner': False, 'url': 'https://doi.org/10.1007/bf02562123'}, {'type': 'PubMed', 'value': '2503341', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/2503341/'}]}
    2. Khubchandani IT, Karamchandani MC, Kleckner FS, et al. Mass screening for colorectal cancer. Dis Colon Rectum. 1989;32:754–8.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '11130566', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/11130566/'}]}
    2. Grazzini G, Castiglione G, Isu A, et al. Colorectal cancer screening by fecal occult blood testing: results of a population-based experience. Tumori. 2000;86:384–8.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/00005650-198610000-00004', 'is_inner': False, 'url': 'https://doi.org/10.1097/00005650-198610000-00004'}, {'type': 'PubMed', 'value': '3762240', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/3762240/'}]}
    2. Thompson RS, Michnich ME, Gray J, Friedlander L, Gilson B. Maximizing compliance with hemoccult screening for colon cancer in clinical practice. Med Care1986:24:904–14.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/00005650-199110000-00009', 'is_inner': False, 'url': 'https://doi.org/10.1097/00005650-199110000-00009'}, {'type': 'PubMed', 'value': '1921523', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/1921523/'}]}
    2. Myers RE, Ross EA, Wolf TA, Balshem A, Jepson C, Millner L. Behavioral interventions to increase adherence in colorectal cancer screening. Med Care. 1991;29:1039–50.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1200/JCO.2007.13.4098', 'is_inner': False, 'url': 'https://doi.org/10.1200/jco.2007.13.4098'}, {'type': 'PubMed', 'value': '18024871', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/18024871/'}]}
    2. Shankaran V, McKoy JM, Dandade N, et al. Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening. J Clin Oncol. 2007 Nov 20;25:5248–53.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/1097-0142(19920901)70:3+<1259::AID-CNCR2820701511>3.0.CO;2-D', 'is_inner': False, 'url': 'https://doi.org/10.1002/1097-0142(19920901)70:3+<1259::aid-cncr2820701511>3.0.co;2-d'}, {'type': 'PubMed', 'value': '1511373', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/1511373/'}]}
    2. Ahlquist DA. Occult blood screening. Obstacles to effectiveness. Cancer. 1992;70:1259–65.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj